LEGNLegend Biotech Corporation American Depositary Shares
Identity
- Security key
- 17976
- Ticker
- LEGN
- Type
- ADRC — American Depository Receipt Common
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-06-05
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- LEGN
Detail
Enriched 2026-08-14 20:47
- Market cap
- $4,001,339,390.3
- Shares outstanding (class)
- 185,739,792
- Shares outstanding (weighted)
- 193,769,462
- SIC
- —
- Employees
- 3,100
- Location
- —
- Homepage
- https://www.legendbiotech.com
- Description
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.